Navigation Links
Study Results Reveal Oral Growth Hormone Boosting Supplement May Be Capable of Producing the Same Benefits as Synthetic Growth Hormone Injections

NEW YORK, Nov. 21, 2013 /PRNewswire/ -- While human growth hormone (hGH) therapy has become a staple among the rich and famous thanks to its notoriety for purportedly being able to reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make people look and feel decades — not years, but DECADES — younger, there has been a marked lack of clinical studies exploring these benefits. That's why a recent study on an oral growth hormone booster's effects on endurance garnered so much attention among experts attending the prestigious Obesity Week Conference held recently in Atlanta, Georgia.

The study revolved around SeroVital®, an hGH secretagogue that's been causing quite a stir at scientific conferences around the world ever since a group of some of the most renowned researchers in the world revealed that it was capable of increasing mean, serum (blood) growth hormone levels by 682%. This was headline news, because up until this point most felt the best way to increase hGH levels was through expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, these synthetic hGH injections are extremely controversial, because some experts fear that introducing synthetic hGH into the body may upset the natural production of hGH.

"That's what makes SeroVital so different," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica International™, SeroVital's distributor. "Rather than introducing synthetic hGH into the body via injections, SeroVital increases the body's own, endogenous levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital not only provides a more affordable way for people to raise their hGH levels, but does so in a clinically validated way that allows users to achieve this naturally and without the risks associated with injections."

And now SeroVital is making news again with the release of a study analyzing its effects on endurance. The results of this study showed that after two weeks of daily supplementation with this patented hGH secretagogue, not only was subjects' VO2max (the established measure of endurance) significantly increased, but numeric increases in both resting metabolic rate and estimated daily calorie expenditure were also seen.

"Increased measures of endurance are a well-established outcome of synthetic recombinant human growth hormone (rhGH) injections in adults," explains Dr. Heaton. "But our research on the SeroVital compound is so exciting because it's the first study of its kind to show that an oral growth hormone secretagogue may be capable of producing an expected benefit the same as that of synthetic hGH injections. And while the present study was not sufficiently powered to detect a significant change in mean resting metabolic rate and estimated daily calorie expenditure, these parameters showed increased values over baseline following the treatment period, evidencing the potential of the supplement to impart long-term fat burning effects."

The promise this research holds — especially because it doesn't require the administration of controversial synthetic hGH injections — could lead to an increased understanding of the ability of youthful growth hormone levels to impact excess body weight and fat mass, which is quickly becoming a major global health hazard. Dr. Heaton adds, "Further research in this area may provide insight to potential effects on body composition and weight regulation by the amino acid based hGH secretagogue. A larger multi-center study is being planned."

For more information about Obesity Week, visit To get the full details on SeroVital, visit You can purchase SeroVital directly from SanMedica International by calling 1-800-285-5192 or Use the promo code SERO43 at checkout and shipping is free.*

*Free standard shipping in the continental U.S. only.

SOURCE SeroVital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
2. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
3. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
4. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
5. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
6. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
7. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
8. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
9. Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
10. Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
11. Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):